Display options
Share it on

Indian J Crit Care Med. 2009 Apr-Jun;13(2):85-91. doi: 10.4103/0972-5229.56054.

Prevalence of occult adrenal insufficiency and the prognostic value of a short corticotropin stimulation test in patients with septic shock.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Muzaffar Maqbool, Zafar Amin Shah, Fayaz Ahmad Wani, Abdul Wahid, Shaheena Parveen, Arjumand Nazir

Affiliations

  1. Department of Immunology Molecular Medicine, Sheri-Kashmir Institute of Medical Sciences, Srinagar 190 001, J&K, India.

PMID: 19881189 PMCID: PMC2772244 DOI: 10.4103/0972-5229.56054

Abstract

BACKGROUND: Corticosteroid insufficiency in acute illness can be difficult to discern clinically. Occult adrenal insufficiency (i.e., Deltamax < or =9 microg/dL) after corticotropin may be associated with a high mortality rate.

OBJECTIVE: To assess the prevalence of occult adrenal insufficiency and the prognostic value of short corticotropin stimulation test in patients with septic shock.

MATERIALS AND METHODS: A total of 30 consecutive patients admitted in the adult intensive care unit of the Sheri Kashmir Institute of Medical Sciences who met the clinical criteria for septic shock were prospectively enrolled in the study. A low dose (1 microg) short corticotropin stimulation test was performed; blood samples were taken before the injection (T0) and 30 (T30) and 60 (T60) minutes afterward.

RESULTS: The prevalence of occult adrenal insufficiency was 57%. The 28-day mortality rate was 60% and the median time to death was 12 days. The following seven variables remained independently associated with death: organ system failure scores, simplified acute physiology score II score, mean arterial pressure, low platelet count, PaO(2):FIO(2), random baseline cortisol (T0) > 34 microg/dL, and maximum variation after test (Deltamax) of < or =9 microg/dL. Three different mortality patterns were observed: (I) low (T0 < or =34 microg/dL and Deltamax > 9 microg/dL; a 28-day mortality rate of 33%),(II) intermediate (T0 > 34 microg/dL and Deltamax> 9 microg/dL or T0 < or =34 microg/dL and Deltamax < or =9 microg/dL; a 28-day mortality rate of 71%), and (III) high (T0 > 34 microg/dL and Deltamax < or =9 microg/dL; a 28-day mortality rate of 82%).

CONCLUSION: A short corticotropin test using low-dose corticotropin (1 microg) has a good prognostic value. High basal cortisol and a low increase in cortisol on corticotropin stimulation test are predictors of a poor outcome in patients with septic shock.

References

  1. Br J Clin Pharmacol. 1998 Dec;46(6):589-97 - PubMed
  2. N Engl J Med. 1996 Oct 17;335(16):1206-12 - PubMed
  3. N Engl J Med. 1995 May 18;332(20):1351-62 - PubMed
  4. Lancet. 1983 Feb 26;1(8322):484 - PubMed
  5. Crit Care Med. 1998 Apr;26(4):627-30 - PubMed
  6. Crit Care Med. 1989 May;17(5):389-93 - PubMed
  7. Crit Care Med. 1996 May;24(5):899-900 - PubMed
  8. Crit Care Med. 1985 Jun;13(6):477-9 - PubMed
  9. J Clin Endocrinol Metab. 1995 Apr;80(4):1243-6 - PubMed
  10. Endocrinology. 1957 Mar;60(3):347-58 - PubMed
  11. N Engl J Med. 1993 Oct 21;329(17):1246-53 - PubMed
  12. Crit Care Med. 1992 Oct;20(10):1395-401 - PubMed
  13. JAMA. 2000 Feb 23;283(8):1038-45 - PubMed
  14. Lancet. 1982 Jun 19;1(8286):1414-5 - PubMed
  15. Am J Respir Crit Care Med. 2006 Dec 15;174(12):1319-26 - PubMed
  16. J Clin Endocrinol Metab. 1998 May;83(5):1558-62 - PubMed
  17. Lancet. 1999 May 15;353(9165):1675-6 - PubMed
  18. Clin Endocrinol (Oxf). 1996 Feb;44(2):151-6 - PubMed
  19. Crit Care Med. 1990 Mar;18(3):259-63 - PubMed
  20. Surgery. 1999 Apr;125(4):431-40 - PubMed
  21. Ann Surg. 1977 Jul;186(1):29-33 - PubMed
  22. Am J Med. 1980 Mar;68(3):344-55 - PubMed
  23. JAMA. 1995 Sep 27;274(12):968-74 - PubMed
  24. JAMA. 1991 Sep 25;266(12):1686-91 - PubMed
  25. Intensive Care Med. 1992;18(2):93-6 - PubMed
  26. Crit Care Med. 1995 Jan;23(1):78-83 - PubMed
  27. J Clin Invest. 1958 Dec;37(12):1791-8 - PubMed
  28. J Clin Endocrinol Metab. 1999 Mar;84(3):838-43 - PubMed
  29. Shock. 2003 Jan;19(1):13-5 - PubMed
  30. Crit Care Med. 1997 Jul;25(7):1095-100 - PubMed
  31. JAMA. 2002 Aug 21;288(7):862-71 - PubMed
  32. Intensive Care Med. 1994 Aug;20(7):489-95 - PubMed
  33. Lancet. 1991 Mar 9;337(8741):582-3 - PubMed
  34. Clin Chem. 1989 Aug;35(8):1675-9 - PubMed
  35. J Trauma. 2001 Oct;51(4):800-14 - PubMed
  36. J Clin Endocrinol Metab. 1988 Aug;67(2):223-7 - PubMed
  37. Intensive Care Med. 1995 Jan;21(1):57-62 - PubMed
  38. JAMA. 1993 Sep 8;270(10):1233-41 - PubMed
  39. J Infect Dis. 1990 May;161(5):982-7 - PubMed
  40. Crit Care Med. 1990 Aug;18(8):801-6 - PubMed
  41. Chest. 1987 Aug;92(2):292-5 - PubMed
  42. N Engl J Med. 1997 Oct 30;337(18):1285-92 - PubMed

Publication Types